Halozyme Therapeutics (HALO) Stock
Halozyme Therapeutics (HALO) closed at $95.97 on Nov 17, 2026; its Tenet Score is 71 of 100 against 340 Healthcare peers.
14 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $95.97
- Nov 17, 2026
- Market cap
- $11.0B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 24.4×
- TTM through Sep 30, 2026 · as of close, Nov 16, 2026
- 52-week range
- 61.23 – 134.00
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 71/100
- Solid · 340 Healthcare peers
Industry: Drugs
Halozyme Therapeutics Inc. scores 71/100. Solid. Strongest on growth and quality, trading at 24× earnings versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✓ Buffett Quality
- ✕ Piotroski F-Score
- ✓ Munger Compounders
- ✕ Magic Formula
- ✕ Graham Defensive
- ✕ Lynch GARP
13F flows & insider trades land here.
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Elanco Animal Health IncELAN | 37 | $13.2B |
| Dr. Reddy's Laboratories Ltd.RDY | 45 | $12.3B |
| Bio-Techne CorpTECH | 51 | $11.4B |
| Biomarin Pharmaceutical Inc.BMRN | 43 | $11.2B |
| Kymera Therapeutics IncKYMR | 41 | $10.7B |
| Repligen Corp.RGEN | 49 | $10.4B |
| Madrigal Pharmaceuticals IncMDGL | 32 | $9.8B |
| TG Therapeutics IncTGTX | 43 | $9.6B |
| Spyre Therapeutics Inc.SYRE | 43 | $9.4B |
| Krystal Biotech IncKRYS | 66 | $8.8B |
Common questions
What sector and industry is Halozyme Therapeutics in?
Halozyme Therapeutics is in the Healthcare sector and the Drugs industry.
What is Halozyme Therapeutics' Tenet Score?
Halozyme Therapeutics' Tenet Score is 71 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




